Filing Flows › Companies › MDU Resources Group › Analysis traps
MDU Resources Group (MDU): analysis traps
Where its figures could mislead a reader, and what to check before taking them at face value · Data: Q3 2026, to Sep 30, 2026, filed Nov 6, 2026; rules v1.1
MDU Resources Group (MDU): 1 rule of 10 triggered on the filings to Sep 30, 2026: low net debt = no refinancing risk. 1 to review; 1 with insufficient data; 2 not applicable. Each is a question to verify, with the normal explanation that would produce the same figures.
Check these first
Low net debt = no refinancing risk Triggered · severity high · confidence medium
$145M of debt comes due within a year against $28M of cash and investments and no free cash flow to add: $117M short, to be refinanced or raised. Net debt of $2.6B says nothing about when the debt falls due.
Innocent reading: A committed, undrawn credit facility covers the gap (not visible in the balance sheet).
A precise DCF value = the true value To review · confidence high
The DCF's point value is 2.39 a share (price 18.63); 116% of it is the terminal value, a number about years no one has seen. Moving wacc by ±1 pt alone takes it from -1.19 to 8.04; across every method the research ran the range is -9 to 68. The value is a range; the decimals are not information.
Innocent reading: A stable, mature business with a narrow range of outcomes, where the point value is a fair summary.
Every rule
A01 FCF growth = the business improved Not triggered confidence high
Free cash flow did not rise (−$21M → −$297M): the trap does not arise.
The figures and how they are read
| Fiscal year before | FY2024 |
| Fiscal year | FY2025 |
| Operating cash flow, year before | $502M |
| Operating cash flow | $473M |
| Capex, year before | $523M |
| Capex | $770M |
| Free cash flow, year before | −$21M |
| Free cash flow | −$297M |
| Change in FCF | −$277M |
| Change in capex | $248M |
| Working capital: change in its cash contribution | $37M |
FCF = operating cash flow − cash capex; ΔFCF = ΔOCF − ΔCapEx; the working-capital part is the change in the cash-bridge items (receivables, inventory, payables, accruals), with the sign of the cash flow statement
Source: FY2025 (cash flow statement, fiscal year) · FY2024 (cash flow statement, fiscal year before)
A07 Stock compensation added back = no economic cost Not triggered confidence high
Stock compensation is 0.3% of revenue: small enough that adding it back changes little.
The figures and how they are read
| Fiscal year | FY2025 |
| Stock compensation | $7M |
| Revenue | $1.9B |
| SBC / revenue | +0.4% |
| Buybacks | 0 |
| Buybacks / SBC | 0.0 |
| Diluted shares, year before | 204.7M shares |
| Diluted shares | 205.3M shares |
| Diluted shares: change | +0.3% |
SBC / revenue from the cash flow statement's add-back; the diluted weighted share count year over year; buybacks from the financing section
Source: FY2025 (stock compensation, buybacks and the diluted share count, fiscal year)
B02 Receivables growing = future cash is certain Not triggered confidence medium
Receivables grew 12% against revenue 10% in Q3 2026; DSO 40 against a median of 36: collections are keeping pace with sales.
The figures and how they are read
| Quarter | Q3 2026 |
| Revenue, year over year | +10.4% |
| Receivables, year over year | +11.9% |
| Quarter before | Q2 2026 |
| Revenue y/y, quarter before | +6.9% |
| Receivables y/y, quarter before | -3.2% |
| Days sales outstanding | 39.6 |
| DSO, median of eight quarters | 36.2 |
| Receivables | $148M |
| Revenue | $348M |
receivables and revenue against the same quarter a year earlier; DSO = receivables / quarterly revenue × days, against the median of the eight quarters before
Source: Q3 2026 (receivables and revenue) · Q3 2025 (the same quarter a year earlier)
B08 Adjusted profit = economic profit Insufficient data
1 quarter with a reconciliation table on file (three are needed) and fewer than three quarters with both an adjusted and a GAAP EPS
C02 Low net debt = no refinancing risk Triggered severity high · confidence medium
$145M of debt comes due within a year against $28M of cash and investments and no free cash flow to add: $117M short, to be refinanced or raised. Net debt of $2.6B says nothing about when the debt falls due.
The figures and how they are read
| Cash and investments | $28M |
| Debt | $2.6B |
| Net debt | $2.6B |
| Due within a year | $145M |
| Read from | the debt maturity table |
| Free cash flow, twelve months | −$320M |
| Cash plus free cash flow | $28M |
| Coverage of what is due | 0.2 |
| Due in the second year | $275M |
| Balance sheet date | 2026-09-30 |
due within a year from the maturity table (else the current portion of debt), against cash and investments plus free cash flow over the last twelve months (zero if negative); no credit lines assumed
Source: FY2025 (debt maturities, cash and investments)
What would explain it innocently
- A committed, undrawn credit facility covers the gap (not visible in the balance sheet)
- The notes are routinely rolled over in the commercial-paper or bond market at an investment-grade rating
- Cash held abroad or in subsidiaries can be moved to where the debt is
- A sale of a business or asset already agreed brings the cash
What to look for in the filing
- Undrawn committed facilities and their covenants
- The cost and rating of the refinancing
- Restricted cash and the operating minimum
What would show the trap does not apply
- The 10-K lists an undrawn credit facility that covers the debt due, or the maturity is refinanced before it falls due
- Cash plus FCF of the next quarter exceeds the debt due within a year
Look again: next filing.
D03 EPS growth = profit growth Not triggered confidence high
EPS fell 26% and net income fell 23% in Q3 2026; the share count rose 3.6%: EPS growth follows profit growth.
The figures and how they are read
| Quarter | Q3 2026 |
| Quarter before | Q3 2025 |
| EPS, year before | $0.09 |
| EPS | $0.07 |
| Net income, year before | $18M |
| Net income | $14M |
| Diluted shares, year before | 205.3M shares |
| Diluted shares | 212.7M shares |
| EPS growth | -25.8% |
| Net income growth | -23.1% |
| Diluted shares: change | +3.6% |
| eps from profit | -$0.02 |
| eps from share count | $0.00 |
EPS and net income against the same quarter a year earlier; the EPS bridge attributes the change to profit first, then to the share count (the order is fixed and disclosed)
Source: Q3 2026 (net income, diluted shares, EPS) · Q3 2025 (the same quarter a year earlier)
E02 Low P/E at a cyclical peak = undervalued Not triggered confidence medium
Net income of $191M is not at a cyclical high against the last eight years (median $367M, best $415M): the P/E of 20.8× is on a normal year.
The figures and how they are read
| market value | $4.0B |
| net income ttm | $191M |
| pe ttm | 20.80 |
| net income median fy | $367M |
| pe mid cycle | 10.80 |
| net income peak fy | $415M |
| years | FY2018 / 272.0; FY2019 / 335.0; FY2020 / 390.0; FY2021 / 378.0; FY2022 / 367.0; FY2023 / 415.0; FY2024 / 281.0; FY2025 / 190.0 |
| down years in window | 4 |
P/E on the trailing twelve months' net income against the P/E on the median net income of the last eight fiscal years (a mid-cycle stand-in); 'at a peak' = this year's profit at or above 90% of the best year and at least 1.3× the median
Source: Q3 2026 (net income, trailing twelve months)
E07 A precise DCF value = the true value To review confidence high
The DCF's point value is 2.39 a share (price 18.63); 116% of it is the terminal value, a number about years no one has seen. Moving wacc by ±1 pt alone takes it from -1.19 to 8.04; across every method the research ran the range is -9 to 68. The value is a range; the decimals are not information.
The figures and how they are read
| dcf value | 2.39 |
| price | 18.63 |
| terminal value share | +115.6% |
| swing by input | WACC / ±1 pt / -1.19 / 8.04; Operating margin / ±3 pts / -1.53 / 6.31; Revenue growth (each year) / ±5 pts / -1.02 / 6.58; Tax rate / ±5 pts / 1.16 / 3.61 |
| range all methods | -8.71; 67.96 |
the DCF's point value against the share of it that is the terminal value and the value at each input moved by one step (growth ±5 pts, WACC ±1 pt, margin ±3 pts …); the range across every method the research ran
Source: 2026-11-08 (valuation research)
What would explain it innocently
- A stable, mature business with a narrow range of outcomes, where the point value is a fair summary
- The inputs that matter most are themselves well known (a regulated return, a long contract)
What to look for in the filing
- Which input you believe differs from the research's and why
- What the price implies for growth (the reverse DCF on the fair-value page)
What would show the trap does not apply
- The DCF's value is robust to the terminal growth and discount rate (the range's low end is still above the price)
- The company's cash flows over the next three years track the DCF's early years
Look again: next filing.
J06 A bank's low P/E and high profit = safe Not applicable
not a bank
J08 A REIT's low net income = the dividend is unsafe Not applicable
not a REIT
What the statuses mean
Triggered: the filings show the pattern; read the normal explanations and the missing evidence before concluding anything. To review: one quarter or a weak signal; a reader's judgement, not a pattern. Not triggered: the pattern is absent on these figures. Insufficient data: the filings read so far do not hold what the rule needs; this is not a clean bill. Not applicable: the rule is not meant for this kind of company (a bank's working capital, a loss-making quarter's EPS growth). Out of date: the latest filing is more than fifteen months old.
Severity is what the pattern could mean for cash, value or solvency; confidence is how reliable the inputs and the reading are. The two are kept apart.
Record a view
A reader's judgement, grounds, what would change it and the next review; kept in the browser (needs JavaScript).
Every rule and the companies it triggers on → MDU Resources Group: cash flow → Earnings quality score →
Each rule reads the company's own filings by a fixed formula and says what would explain the same figures innocently. A triggered rule is a question to verify, not a finding of manipulation, and not a view on the stock. Missing data is shown as missing, never as clear. Not investment advice.